- Profile
- Personal Information
- Publications
Experts in Toxicology
Dr. Rama Kant Singh KREMZER Oleksandr Andreevich Vladimir Katanaev Marie-Christine Broillet Karen L. Martin Rhonda Rosengren Lauren Aleksunes Kenneth Bart Kousik Pramanick Shankar Munusamy Dr. Sharad Sharma Dr. Srikanta Kumar Rath DR. Raj Kamal Tripathi Dr. Aamir Nazir Dr. Sarika Singh Kenneth S. Korach Danielle Carlin Freya Kamel Abhayachandran.K Dr. Pradeep Bhatnagar View MoreReema Jasuja, PhD, is a Principle Scientist in Pfizer’s Rare Disease Research Unit. Dr. Jasuja joined Pfizer in Cambridge, MA in 2012, and contributed to efforts in hematology projects across the Rare Disease Research Unit, including sickle cell disease and hemophilia. She has worked extensively with in vivo models of both hemophilia and sickle cell disease. Dr. Jasuja did the preclinical work around Tissue Factor Pathway Inhibitor, which achieved Proof-of-Mechanism in 2016 for prophylaxis in hemophilia. She has also worked extensively across sickle cell disease projects including preclinical studies on PDE9 inhibitor for sickle cell disease. Additionally, she is the research program lead of an early stage program on Erythroferrone antibody, for managing iron overload in patients with thalassemia and other rare forms of anemias leading to iron overload.
Deseases & Pharmacy